Trial intelligence / Profile preview

Autologous MSCs for knee osteoarthritis

NCT02351011Phase 2Completed

Start
Feb 2015
Primary completion
Dec 2018
Modality
Mesenchymal Stem Cells
Countries
1
01

Overview

Phase 2, open-label trial of Provacel in osteoarthritis of the knee (OA). Started Feb 2015; status: completed.

02

Drugs

Provacel
03

Conditions

osteoarthritis of the knee (OA)

Beyond the preview

Go deeper on NCT02351011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02351011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call